Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease

NCT03256539 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03256539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03256539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Terminated
Start date
August 12, 2021
Completion date
January 31, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, alzheimer disease, cbt, cognitive impairment, sleep